Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
Blood|August 12, 2008
Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivityKatrin M Baltz, Matthias Krusch, Tina Baessler, et al.
Frontiers in Immunology|February 13, 2024
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccinationAnnkristin Heine, Niels A W Lemmermann, Chrystel Flores, et al.
International Journal of Molecular Sciences|June 26, 2026
Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma CellsSascha Kampmann, Sebastian Schlaweck, Benjamin V Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2024
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibitionJonas Saal, Tobias Bald, Markus Eckstein, et al.
STAR Protocols|May 2, 2022
Quantification of unperturbed phosphoprotein levels in immune cell subsets with phosphoflow to assess immune signaling in autoimmune diseaseCalvin Krollmann, Kevin Cieslak, Ruth-Miriam Koerber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005
Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responsesAnnkristin Heine, Frank Grünebach, Tobias Holderried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approachesMartin R Müller, Frank Grünebach, Katrin Kayser, et al.
Oncoimmunology|March 5, 2016
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitorsStefanie Andrea Erika Held, Annkristin Heine, Anne Ruth Kesper, et al.
Scientific Reports|February 14, 2018
Murine hematopoietic stem cell reconstitution potential is maintained by osteopontin during agingJin Li, Carmen Carrillo García, Tamara Riedt, et al.
Current Cancer Drug Targets|August 3, 2013
Advances in immunotherapy of chronic myeloid leukemia CMLStefanie Andrea Erika Held, Annkristin Heine, Karin Tina Mayer, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
Blood|August 12, 2008
Neutralization of tumor-derived soluble glucocorticoid-induced TNFR-related protein ligand increases NK cell anti-tumor reactivityKatrin M Baltz, Matthias Krusch, Tina Baessler, et al.
Frontiers in Immunology|February 13, 2024
Rapid protection against viral infections by chemokine-accelerated post-exposure vaccinationAnnkristin Heine, Niels A W Lemmermann, Chrystel Flores, et al.
International Journal of Molecular Sciences|June 26, 2026
Inhibition of Fibroblast Growth Factor Receptor 3 Signaling by Ponatinib Reduces Growth and Cytokine Production of Multiple Myeloma CellsSascha Kampmann, Sebastian Schlaweck, Benjamin V Becker, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2024
Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibitionJonas Saal, Tobias Bald, Markus Eckstein, et al.
STAR Protocols|May 2, 2022
Quantification of unperturbed phosphoprotein levels in immune cell subsets with phosphoflow to assess immune signaling in autoimmune diseaseCalvin Krollmann, Kevin Cieslak, Ruth-Miriam Koerber, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005
Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responsesAnnkristin Heine, Frank Grünebach, Tobias Holderried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approachesMartin R Müller, Frank Grünebach, Katrin Kayser, et al.
Oncoimmunology|March 5, 2016
Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitorsStefanie Andrea Erika Held, Annkristin Heine, Anne Ruth Kesper, et al.
Scientific Reports|February 14, 2018
Murine hematopoietic stem cell reconstitution potential is maintained by osteopontin during agingJin Li, Carmen Carrillo García, Tamara Riedt, et al.
Current Cancer Drug Targets|August 3, 2013
Advances in immunotherapy of chronic myeloid leukemia CMLStefanie Andrea Erika Held, Annkristin Heine, Karin Tina Mayer, et al.
Pageof 27